Run pharma S&OP around service, inventory and capacity choices

The meeting needs a decision to make

Commercial teams approve a growth forecast, manufacturing approves a capacity plan and finance approves a lower inventory target. Each plan looks reasonable in isolation. Together, they require more supply, less stock and fewer production hours than the site can deliver.

Pharma sales and operations planning, or S&OP, should expose these conflicts before they become emergency decisions. Its output is an agreed operating plan and an explanation of the trade-offs accepted by accountable leaders. A monthly deck showing departmental results is useful reporting, but it does not perform this reconciliation by itself.

Begin with the decisions that repeatedly escape the meeting: whether to build stock before a shutdown, reserve a contractor's capacity, change a launch date or accept a service shortfall. Set the planning horizon to cover the relevant lead times. A three-month view cannot resolve an option that requires six months of preparation.

Build one set of assumptions

Agree product families, units, reporting periods and the definition of demand. A revenue forecast and a pack forecast cannot be compared without prices, product mix and timing. Likewise, total inventory value does not reveal whether the right products have sufficient remaining shelf life for their intended markets.

The demand input should distinguish underlying demand, channel stocking, confirmed orders and management targets. The guide to pharma demand forecasting explains this separation. S&OP then decides how to respond, rather than trying to settle every transaction-level discrepancy during the leadership meeting.

For supply, include approved capacity, material usability, laboratory and review work, packaging constraints and planned engineering interruptions. Do not count a production completion as immediate saleable supply. Each scenario should use the same definition of when a quantity becomes eligible for the intended customer or market.

For inventory, distinguish saleable stock, restricted stock, work in progress and committed quantities. WHO's medical-product distribution guidance provides relevant stock-control context; it does not prescribe this S&OP design or its financial objectives. WHO storage and distribution guidance.

Worked example of campaign stock versus launch timing

Consider an illustrative manufacturer with an engineering shutdown planned for the next quarter. An established product needs 20,000 packs during the shutdown period. A new launch also requires the same production line beforehand. The team compares two scenarios using identical material-release and production assumptions.

Scenario A produces an extra 10,000 packs of the established product before the shutdown and moves the launch campaign later. Scenario B keeps the launch campaign and accepts a 10,000-pack shortfall in the established product during the affected period. Assume the remaining 10,000 packs are available through existing eligible stock. These are simplified planning quantities, not demand or outcome claims.

Scenario A combines those 10,000 existing packs with 10,000 newly produced packs to cover the 20,000-pack demand. If the incremental stock costs ₹100 per pack, its initial inventory exposure is ₹10 lakh. That is cash tied up in stock, not automatically an expense or permanent loss. Finance should model the timing of production payments and subsequent collections separately from accounting recognition.

The table does not choose the answer. Leadership needs the contribution, contractual exposure, market commitments and inventory suitability behind each option. If the extra stock would have insufficient remaining shelf life for the intended customers, Scenario A may be infeasible despite its apparent service benefit.

Record the chosen scenario with a trigger for review. For example, a material-release delay beyond an agreed checkpoint may invalidate the pre-shutdown campaign. The plan should say who reconvenes the decision and which alternative becomes available; a risk statement with no trigger is easy to ignore.

Separate constraints from business preferences

Quality requirements and authorised product status are not variables that the S&OP committee can relax to improve the financial result. The meeting can choose a later shipment, additional qualified capacity or a different approved route where available. It cannot create eligibility by accepting a commercial risk.

Business preferences are different. Finance may prefer lower inventory, commercial may prefer a launch date and operations may prefer fewer changeovers. Put these preferences into explicit scenarios so their consequences can be compared. Avoid calling every departmental preference a hard constraint.

For outsourced production, a reserved slot should carry its technical dependencies. The CDMO capacity-planning guide explains why a paid reservation can remain conditional. S&OP should see both the capacity option and the unresolved readiness work before treating it as committed supply.

Design the cycle around preparation and escalation

Use working sessions to reconcile data and develop options before the executive meeting. Demand owners explain material changes; supply owners identify feasible responses; finance compares the same scenarios on a consistent basis. Escalate only decisions that exceed the working team's authority or require a cross-functional trade-off.

A practical decision paper can be short. State the decision, deadline, baseline, two or three credible options, common assumptions, financial consequences, service consequences and recommendation. Attach supporting detail for reviewers who need it. A large collection of departmental slides makes it harder to identify the actual choice.

After the meeting, publish the accepted plan version and decision record. Include who owns each action, when it is due, what evidence closes it and what event requires reconsideration. Preserve rejected options where they explain a later decision, but prevent obsolete versions from appearing as the current operating plan.

Measure whether decisions survive contact with operations

Plan adherence matters, but the explanation for a miss is more useful than a single percentage. Separate forecast change, supply disruption, unmaintained master data, late approval and a decision that was never executed. This prevents the meeting from repeatedly treating an execution problem as a forecasting problem.

Track decision latency: the elapsed time between a material conflict becoming visible and an authorised choice being recorded. A shorter cycle is valuable only if the evidence remains adequate. Also track how many actions are overdue and how often the same unresolved issue returns without a changed option.

Review inventory and service together. Lower stock can look successful while creating avoidable shortages. Higher service can look successful while building ageing inventory. The right interpretation depends on the accepted business policy and product constraints, not a universal benchmark.

Choose software after agreeing the operating model

A spreadsheet can support an initial cycle if definitions, versions and ownership are controlled. Its limitations become material when many sites edit scenarios, inputs change frequently or decisions require traceable links to source records. A planning platform should solve those coordination problems rather than merely reproduce the same fragmented deck online.

Require the system to preserve assumptions, show scenario differences and record accepted decisions. Test whether a late source update is visible, whether users can reproduce the numbers presented last month and whether an unauthorised edit can change the approved plan.

NextEdge Labs can connect the planning inputs and build a decision workflow around the existing management process. Evaluate that investment using the pharma automation ROI framework, with measured baseline effort and benefits that are not counted twice across departments.

Summary and next actions

Effective S&OP makes incompatible departmental plans visible and turns them into explicit choices. The standard is a feasible plan with shared assumptions, accountable decisions and triggers that tell the business when it must reconsider.

• List the three cross-functional decisions that the current planning cycle repeatedly postpones.
• Agree common definitions for demand, usable supply, inventory and financial timing.
• Prepare two feasible scenarios for one live constraint, including service and shelf-life consequences.
• Record the accepted option, action owners and review triggers, then check execution in the next cycle.